Page 75 - Sohini Das

Asia Healthcare-backed single-specialty clinics grew during pandemic

AHH now plans to make similar investments with focus on nephrology, gastroenterology, and ophthalmology among others

Gennova's mRNA vaccine to come in powder form; will stay stable at 2-8 °C

The lyophilized vaccine will come in a powder form and it will be mixed with diluents before administration

Syringe makers ramp up production, fear demand may soon outstrip supply

The Centre is looking to procure around 1 billion syringes between September and December to support the Covid-19 vaccination drive

Corporate hospitals expect double-digit revenue growth in FY22: Icra

Blended occupancy of Covid and non-Covid patients was 64.2% in Q1FY22 as against 36.9% in Q1FY21 and 58.8% in Q4FY21. Therefore, the growth is not just on a low base, but also sequential

Lupin, Glenmark shift focus to inhalation and nasal Covid-19 drugs

Lupin working on remdesivir powder inhaler; Glenmark to do trials on Nitric Oxide Nasal Spray

Covid-19 pandemic: First dose-seekers helped drive record vaccination

Business Standard looked at the top five states contributing the most to the record

How India's health ecosystem is preparing for third Covid-19 wave

Crisis management: Oxygen plants at hospitals, doctors & nurses on standby, ICU beds, buffer stock

Molbio Diagnostics developing more tests for Truenat platform

Molbio is preparing test kits for zika, cholera, nipah, sickle cell anaemia, ch­olera, influenza, mumps, syp­hillis, yellow fever, HIV2 etc

Explained: What FDA full approval to Pfizer-BioNTech vaccine means

The research to develop a safe and effective Covid-19 vaccine was accelerated in 2020

Gennova's mRNA vaccine gets DCGI nod to start phase-2 and 3 trials

If things go according to plan, the vaccine would be available in the market by the end of this year, sources said

Work on non-Covid vaccines gives pharma firms an injection of hope

Approach drug regulator, seeking permission to conduct clinical trials

Zydus to soon start work on developing a vaccine for Delta variant

Also plans trials for children aged three years and above. Its needle-free injection is to be assembled in India

Astrazeneca-Sputnik jabs in combo show a better immune response: RDIF

Preliminary results from Azerbaijan trials have been announced

Johnson & Johnson seeks nod for Covid vaccine trial on adolescents

To achieve herd immunity, studies have to be done on children, pharma major says

Zydus Cadila's Covid vaccine for children above 12 years gets EUA in India

Zydus Cadila's three-dose ZyCoV-D will be administered through needle free injection system

Expert panel green signals Cadila's 3-dose DNA plasmid vaccine ZyCoV-D

DCGI nod expected soon; vaccine stable at room temperatures

J&J seeks nod to start Covid vaccine trials on 12-17 age group in India

Studies show the US company's vaccine has 66 percent efficacy against preventing moderate to severe Covid-19.

Shapoorji Mistry and Dadachanji-led Kaisha Group to enter pharma space

Plans to launch brands in antacids, analgesics, blood thinners, bump up hiring

Single dose Sputnik Light shows 93.5% efficacy against Covid, claims RDIF

Sputnik Light tested on 320,000 subjects; no jab-related deaths; no cerebral vein thrombosis and no Guillain-Barre syndrome

Fortis posts Q1 profit of Rs 430 cr on revenue growth, exceptional gain

Revenue grows 132% in Q1FY22, with that from diagnostics putting up the best show